to a molecular mass of roughly 500 kDa (lanes 5 through
proteins. In vitro studies further revealed that the contain a shortened RG tail [i.e., B(1-168); lane 1] or lack
pICln complex inhibits the spontaneous assembly of an RG-tail (i.e., D2, E, F, and G; lanes 1 through 3) were Sm proteins onto a U snRNA. This effect is efficiently modified. Importantly, methylation in the peak mediated by pICln via its binding to the Sm fold of fractions was specific for Sm proteins, as neither GST nor Sm proteins, thereby preventing specific histone 2A (an often-used model substrate for methylinteractions between Sm proteins required for the transferases [14] ) were modified (lanes 5 and 6). To anaformation of the Sm core. Our data suggest that lyze whether the Sm proteins received a symmetrical (s) the pICln complex regulates an early step in the or asymmetrical (a) DMA modification, we took advantage assembly of U snRNPs, possibly the transfer of Sm of the previous observation that only sDMA-modified Sm proteins to the SMN-complex. proteins can bind to SMN [10] . Thus, endogenous SMN should copurify with an Sm protein subsequent to incu- show that HeLa cytosol contains a methyltransferase activity that specifically introduces sDMA residues into the RG-rich tails of Sm proteins.
Results and discussion
Identification of a sDMA-modifying activity for Sm The pICln complex catalyzes the formation proteins in HeLa cytosol of sDMAs in Sm proteins
To identify the factor(s) that catalyze the formation of pICln has previously been shown to be associated with Sm proteins and the type II (sDMA-generating) arginine sDMAs in Sm proteins, we initially fractionated HeLa N-methyltransferase PRMT5 [13, 15, 16] . It was therefore identify the 200 kDa component have not yet been obtempting to speculate that this complex accounted for tained. the methyltransferase activity observed in our assay (see Figure 1 ). To test for this possibility, we initially isolated the pICln complex by anti-pICln immunoaffinity chromaNext, the pICln complex was purified as described above and tested for methyltransferase activity. As shown in tography and identified the proteins by MALDI-TOF and Western blotting. Consistent with previous reports Figure 2b , SmD1 was strongly modified by the affinitypurified pICln complex (lane 1), whereas the flow through [13] , this complex contains pICln, PRMT5, and all Sm proteins (i.e., B/BЈ, D1, D2, D3, E, F, and G; Figure 2a , of the column was inactive (lane 4). In contrast, no methylation of SmD1 could be detected in a control purification lane 3). In addition, two proteins with apparent molecular masses of 45 kDa and 200 kDa also coeluted specifically using a nonrelated antibody (lanes 2 and 3). In the view of these data, we conclude that the pICln complex generates from the column. The 45 kDa component (termed "WD45") was identified as a WD motif protein of unsDMA residues in Sm proteins. Importantly, antibodies directed against PRMT5 reduced significantly the methknown function that shares pronounced similarity with ␤-transducin (see the Supplementary material available ylation activity of the pICln complex (Figure 2b,c) . This observation together with the previous finding that isowith this article online). This protein is likely to be identical to a factor termed "IBP42," which had previously lated PRMT5 catalyzes the formation of sDMA in a variety of substrates in vitro suggests that PRMT5 is the been identified [13] . Peptide masses that unequivocally 
catalytic component of the pICln complex that generates compare lanes 4 and 5). In contrast, binding of the U1 snRNP-specific protein A was not affected (lanes 4 and sDMA in Sm proteins in vivo. 5 ). Next, we tested whether the observed inhibition of assembly could be attributed to pICln alone, as a previous
The pICln complex inhibits assembly of U snRNPs in vitro study had suggested [13] . Indeed, when snRNP proteins
by binding to the Sm domain of Sm proteins
were preincubated with recombinant pICln, formation of We next tested whether the pICln complex fulfills, apart complex M was abolished (Figure 3b , compare lane 7 from its methyltransferase activity, an additional role in with lanes 2 and 5). Importantly, an inhibition of assembly the biogenesis of U snRNPs as suggested previously [13] .
was strongly dependent on preincubation of pICln with For this purpose, native U snRNP proteins, including Sm proteins, and no effect was observed when pICln was all sDMA-modified Sm proteins (termed "TPs"), were added after the reconstitution reaction had been comprepared from affinity-purified nuclear U snRNPs and pleted (compare lanes 7 and 8). Thus, pICln is more likely incubated with in vitro transcribed and 32 P-labeled U1 to prevent binding of Sm proteins onto U snRNA than snRNA. U snRNP complex formation was subsequently to disassemble the formed U snRNP. analyzed by native gel electrophoresis. In agreement with previous findings, the U1 snRNA was shifted to two complexes, termed "R1" and "M" (Figure 3b, lane 2) . AntiTo analyze the underlying mechanism of pICln's function, we tested whether pICln binds directly to Sm proSm antibodies supershifted complex M (lane 3), indicating that it contains the Sm core assembled on U1 snRNA.
teins and which domains are involved. Recombinant GST-pICln was immobilized on glutathione Sepharose Complex R1 does not contain Sm proteins and corresponds to U1 snRNA bound to the U1A protein (lane beads and subsequently incubated with the bacterially expressed and hence unmethylated Sm complexes 3, see also [9] for a detailed characterization of these complexes). To test whether the pICln complex can inter-D1/D2, E/F/G, and B(1-168)/D3. As shown in Figure 4a , each Sm complex bound efficiently to pICln, whereas fere with U snRNP assembly, we isolated a pICln-containing complex under conditions that allowed for the only marginal binding to GST was observed (compare lanes 8 through 10 with 14 through 16). None of the Sm coisolation of all previously described components except for the Sm proteins (i.e., pICln, PMRT5, WD45, and complexes bound to a significant amount to the GST-SMN1-160 fragment, confirming that this interaction is p200; Figure 3a , lane 4). The pICln(⌬Sm) complex was then incubated with TPs, and assembly was analyzed as enhanced upon sDMA modification of Sm proteins (lanes 11 through 13) [10] . In contrast, sDMA-modified Sm prodescribed above. Strikingly, when this complex was added to an assembly reaction, the formation of the U1 snRNP teins obtained from isolated HeLa-U snRNPs bound equally well to pICln and SMN (Figure 4b , compare lanes was severely impaired as compared to a control reconstitution lacking purified pICln(⌬Sm) complex (Figure 3b,  2 and 3) . These results show that pICln interacts directly the tail domain and hence consists of the Sm domain only bound efficiently to immobilized GST-pICln (Figure 4c , lane 7). In control reactions, no interaction of this mutant was observed with GST-SMN1-160 (which requires the sDMA-modified tails for interaction) or GST alone ( lanes  1 and 4) . Moreover, a double point mutation within the Sm domain (L58 was substituted with K, and I60 was substituted with R) abolished binding of SmD1 to pICln but not to SMD3 (compare lanes 3, 6, and 9). Similar results were obtained with SmB (data not shown). These observations provide strong support for a direct binding of pICln onto the Sm domain of Sm proteins (see Figure  4d for a model). Moreover, the mode of interaction between both proteins implies that pICln inhibits UsnRNP assembly by preventing contacts among Sm proteins required for the formation of the heptameric ring in the Sm core.
Friesen et al. [10] have recently reported that the presence of symmetrical dimethylarginines (sDMAs) in the Sm proteins D1 and D3 is a prerequisite for binding of these proteins to SMN and hence for the assembly onto U snRNA. Here we have shown that the macromolecular pICln complex mediates the formation of sDMAs in SmD1 and SmD3. Consistently, this complex contains as the catalytic subunit the type II methyltransferase PRMT5 [14] . It is interesting to note that isolated PRMT5 methylates a variety of different proteins, including Sm proteins, histones, myelin basic protein, and fibrillarin [14] . In striking contrast, the 500 kDa pICln complex in an in vitro reconstitution assay. Importantly, pICln and 7), D1 (lanes 2, 5, and 8), and D1(M58/60) (lanes 3, 6, and binds to the Sm domain, i.e., the common structure found in all Sm proteins. As Sm proteins interact via this Sm domain to form the heptameric ring of the Sm core, it is likely that pICln inhibits assembly by preventing the formation of specific contacts among Sm proteins. with Sm proteins but, unlike SMN, does not require the presence of sDMAs for binding.
Our data are consistent with a dual function of the pICln complex at an early stage of U snRNP assembly. We The binding of pICln to all Sm heterooligomeric complexes suggested that this interaction involves the Sm propose that newly synthesized Sm proteins initially bind to the pICln complex where B/BЈ, D1, and D3 receive domain, i.e., the N-terminal sequence that is common to Sm proteins and required for the formation of the Sm the sDMA-modification. The pICln complex may then control the transfer of the Sm proteins onto the SMN core. Indeed, a radiolabeled SmD1 translate that lacks complex to allow their subsequent assembly onto a U snRNA.
Supplementary material
Supplementary material including materials and methods and the amino acid sequence of a novel WD domain-containing protein is available at http://images.cellpress.com/supmat/supmatin.htm.
